ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | April 5, 1974

Download PDF Visit The Full Archive

Related Articles

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

September 18, 2009

Fox Chase Biochemist Automates DNA Production

July 20, 1990